Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, San Diego
La Jolla, California, United States
- University of California Irvine, Chao Family Comprehensive Cancer Center
Orange, California, United States
- Miami Cancer Institute at Baptist Health
Miami, Florida, United States
- Uf Health Cancer Center at Orlando Health
Orlando, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- University of Rochester
Rochester, New York, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 May 2017
- Primary completion
- 15 Oct 2019
- Completion
- 15 Oct 2019
- Last update posted
- 2 Jun 2021
- Registered enrollment
- 3
- Registry id
- NCT02743078
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.